Nivolumab in Previously Treated SCLC: Encouraging, but Still Awaiting the Complete Story
- PMID: 30683290
- DOI: 10.1016/j.jtho.2018.11.009
Nivolumab in Previously Treated SCLC: Encouraging, but Still Awaiting the Complete Story
Comment on
-
Third-Line Nivolumab Monotherapy in Recurrent SCLC: CheckMate 032.J Thorac Oncol. 2019 Feb;14(2):237-244. doi: 10.1016/j.jtho.2018.10.003. Epub 2018 Oct 10. J Thorac Oncol. 2019. PMID: 30316010 Free PMC article. Clinical Trial.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
